Skip to content

Pancreatic intra-operative NOdal status: should it influence DEcision making during pancreatoduodenectomy in patients with pancreatic or periampullary cancer?

Pancreatic intra-operative NOdal status: should it influence DEcision making during pancreatoduodenectomy in patients with pancreatic or periampullary cancer? A prospective multicenter observational cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON28118
Enrollment
700
Registered
2020-03-02
Start date
2015-10-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic or periampullary malignancy

Interventions

Standard resection and marking of lymph node stations 8a, 9 and 16b1 during resection of pancreatic or peri-ampullary cancer with pancreatoduodenectomy. Each center can follow routine practice and sam

Sponsors

Amsterdam UMC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Adult patients (> 18 yrs) - Pancreatoduodenectomy (either classic Whipple or pylorus preserving) for suspected pancreatic or periampullary malignancy

Exclusion criteria

Exclusion criteria: - Other active malignancy or previous history of any malignancy if not treated with curative intent >5 years previously - Pregnancy

Design outcomes

Primary

MeasureTime frame
Investigate the effect of lymph node metastases in stations 8a, 9 and 16b1 on overall survival in patients undergoing (classical Whipple or pylorus preserving) pancreatoduodenectomy for pancreatic or peri-ampullary cancer.

Secondary

MeasureTime frame
To determine: 1. The prevalence of lymph node metastases in stations 8a, 9 and 16b1 in histopathologically proven pancreatic or peri-ampullary cancer. 2. In-hospital mortality / conditional survival

Contacts

Public ContactBobby Pranger

University Medical Center Groningen

b.k.pranger@umcg.nl050-36114430

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)